Vanguard Group’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $62.6M | Buy |
|
|||||
|
2018
Q2 | $43.2M | Buy |
|
|||||
|
2018
Q1 | $21.6M | Buy |
|
|||||
|
2017
Q4 | $6.97M | Buy |
|
|||||
|
2017
Q3 | $2.12M | Buy |
|
|||||
|
2017
Q2 | $1.99M | Sell |
|
|||||
|
2017
Q1 | $4.19M | Buy |
|
|||||
|
2016
Q4 | $3.79M | Buy |
|
|||||
|
2016
Q3 | $4.49M | Buy |
|
|||||
|
2016
Q2 | $4.16M | Buy |
|
|||||
|
2016
Q1 | $4M | Buy |
|
|||||
|
2015
Q4 | $4.94M | Buy |
|
|||||
|
2015
Q3 | $5.54M | Buy |
|
|||||
|
2015
Q2 | $6M | Buy |
|
|||||
|
2015
Q1 | $6.74M | Buy |
|
|||||
|
2014
Q4 | $6.42M | Buy |
|
|||||
|
2014
Q3 | $6.06M | Sell |
|
|||||
|
2014
Q2 | $6.8M | Buy |
|
|||||
|
2014
Q1 | $24.1M | Buy |
|
|||||
|
2013
Q4 | $9.53M | Sell |
|
|||||
|
2013
Q3 | $12.2M | Buy |
|
|||||
|
2013
Q2 | $11.5M | Buy |
|